Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Establishment Labs Holdings Inc. is a global medical technology company focused on enhancing women's health, particularly in breast aesthetics and reconstruction [3] - The company will present at the 44th Annual J.P Morgan Healthcare Conference on January 14, 2026, at 9:45 a.m. PT [1] Company Overview - Establishment Labs offers a range of solutions for breast health, aesthetics, and reconstruction in over 90 countries, having delivered over four million Motiva® devices since 2010 [3] - The company's product portfolio includes minimally invasive technologies such as Mia Femtech® for breast harmonization and Preservé® for breast augmentation and revision [3] - The Motiva Flora® tissue expander is the only regulatory-approved expander globally with an integrated port using radio-frequency technology, which is MRI conditional [3] - Establishment Labs has over 200 patent applications across 20 patent families and has published over 100 scientific and clinical studies in peer-reviewed journals [3] - The company operates two manufacturing facilities in Costa Rica that comply with ISO13485:2016 and FDA 21 CFR 820 standards [3]